-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
StockNews.com Begins Coverage on DaVita (NYSE:DVA)
StockNews.com Begins Coverage on DaVita (NYSE:DVA)
StockNews.com initiated coverage on shares of DaVita (NYSE:DVA – Get Rating) in a report issued on Thursday. The firm issued a buy rating on the stock.
Other analysts have also recently issued research reports about the stock. Cowen boosted their target price on shares of DaVita from $76.00 to $90.00 and gave the company an outperform rating in a report on Thursday, February 23rd. Truist Financial boosted their target price on shares of DaVita from $84.00 to $90.00 and gave the company a hold rating in a report on Thursday, February 23rd. Deutsche Bank Aktiengesellschaft boosted their target price on shares of DaVita from $72.00 to $85.00 in a report on Thursday, February 23rd. Finally, Sanford C. Bernstein initiated coverage on shares of DaVita in a report on Tuesday, March 7th. They set a market perform rating on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of Hold and a consensus price target of $86.43.
Get DaVita alerts:DaVita Stock Performance
NYSE:DVA opened at $76.77 on Thursday. The stock has a market cap of $6.94 billion, a P/E ratio of 13.28, a price-to-earnings-growth ratio of 1.56 and a beta of 0.95. The firm's fifty day simple moving average is $80.83 and its 200 day simple moving average is $80.52. DaVita has a twelve month low of $65.28 and a twelve month high of $124.81. The company has a quick ratio of 1.16, a current ratio of 1.20 and a debt-to-equity ratio of 9.92.
DaVita (NYSE:DVA – Get Rating) last released its quarterly earnings results on Wednesday, February 22nd. The company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.23. DaVita had a net margin of 4.83% and a return on equity of 74.02%. The business had revenue of $2.92 billion for the quarter, compared to analysts' expectations of $2.93 billion. During the same quarter in the previous year, the business posted $2.02 earnings per share. The firm's revenue for the quarter was down .9% compared to the same quarter last year. As a group, research analysts predict that DaVita will post 5.93 EPS for the current year.
Insider Buying and Selling
In other DaVita news, Director Charles Berg sold 735 shares of the business's stock in a transaction dated Wednesday, March 1st. The stock was sold at an average price of $81.78, for a total value of $60,108.30. Following the completion of the transaction, the director now owns 17,164 shares of the company's stock, valued at approximately $1,403,671.92. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.00% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On DaVita
A number of hedge funds have recently bought and sold shares of the business. Captrust Financial Advisors raised its position in DaVita by 3.7% in the 1st quarter. Captrust Financial Advisors now owns 3,860 shares of the company's stock worth $437,000 after buying an additional 139 shares during the last quarter. GHP Investment Advisors Inc. increased its position in shares of DaVita by 0.3% during the 2nd quarter. GHP Investment Advisors Inc. now owns 46,865 shares of the company's stock valued at $3,747,000 after purchasing an additional 144 shares during the last quarter. Sentry Investment Management LLC increased its position in shares of DaVita by 63.4% during the 4th quarter. Sentry Investment Management LLC now owns 371 shares of the company's stock valued at $28,000 after purchasing an additional 144 shares during the last quarter. Parkside Financial Bank & Trust increased its position in shares of DaVita by 88.6% during the 1st quarter. Parkside Financial Bank & Trust now owns 313 shares of the company's stock valued at $35,000 after purchasing an additional 147 shares during the last quarter. Finally, Wetherby Asset Management Inc. increased its position in shares of DaVita by 8.1% during the 1st quarter. Wetherby Asset Management Inc. now owns 2,050 shares of the company's stock valued at $232,000 after purchasing an additional 154 shares during the last quarter. Hedge funds and other institutional investors own 86.52% of the company's stock.
DaVita Company Profile
(Get Rating)
DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.
Featured Stories
- Get a free copy of the StockNews.com research report on DaVita (DVA)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don't Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com启动了对以下股票的报道DaVita(纽约证券交易所:DVA-GET评级)在周四发布的一份报告中。该公司对该股的评级为买入。
其他分析师最近也发布了关于该股的研究报告。考恩在2月23日周四的一份报告中将DaVita的股票目标价从76.00美元上调至90.00美元,并给予该公司表现优于大盘的评级。Truist Financial在2月23日周四的一份报告中将DaVita的股票目标价从84.00美元上调至90.00美元,并给予该公司持有评级。德意志银行Aktiengesellschaft在2月23日星期四的一份报告中将DaVita的股票目标价从72.00美元上调至85.00美元。最后,桑福德·C·伯恩斯坦在3月7日星期二的一份报告中对DaVita的股票进行了报道。他们为这只股票设定了市场表现评级。一名投资分析师将该股评级为卖出,五名分析师给出了持有评级,两名分析师给出了该公司股票的买入评级。根据MarketBeat.com的数据,该公司目前的平均评级为持有,共识目标价为86.43美元。
到达达维塔警报:达维塔股票表现
纽约证券交易所:DVA周四开盘报76.77美元。该股市值为69.4亿美元,市盈率为13.28倍,市盈率为1.56倍,贝塔系数为0.95。该公司的50日简单移动均线为80.83美元,200日简单移动均线为80.52美元。DaVita的12个月低点为65.28美元,12个月高位为124.81美元。该公司的速动比率为1.16,流动比率为1.20,债务权益比为9.92。
DaVita(纽约证券交易所代码:DVA-GET Rating)最近一次发布季度收益报告是在2月22日星期三。该公司公布本季度每股收益为1.11美元,比普遍预期的0.88美元高出0.23美元。DaVita的净利润率为4.83%,股本回报率为74.02%。该业务当季营收为29.2亿美元,高于分析师预期的29.3亿美元。在去年同一季度,该业务公布的每股收益为2.02美元。与去年同期相比,该公司本季度的收入下降了0.9%。研究分析师预测,作为一个整体,DaVita本年度的每股收益将达到5.93美元。
内幕买卖
在达维塔的其他新闻中,董事查尔斯·伯格在一笔日期为3月1日星期三的交易中出售了735股该公司的股票。这只股票的平均售价为81.78美元,总价值为60,108.30美元。交易完成后,董事现在拥有该公司17,164股股票,价值约1,403,671.92美元。这笔交易是在提交给美国证券交易委员会的法律文件中披露的,该文件可通过这个环节。1.00%的股份目前由公司内部人士持有。
对冲基金对达维塔的看法
一些对冲基金最近买卖了该公司的股票。CapTrust Financial Advisors在第一季度将其在DaVita的头寸提高了3.7%。CapTrust Financial Advisors现在拥有3860股该公司股票,价值43.7万美元,在上个季度又购买了139股。GHP Investment Advisors Inc.在第二季度将其在DaVita股票的持仓增加了0.3%。GHP Investment Advisors Inc.现在持有46,865股该公司股票,价值3,747,000美元,该公司在上个季度又购买了144股。哨兵投资管理公司在第四季度将其在DaVita股票的头寸增加了63.4%。在上个季度增持了144股后,哨兵投资管理公司现在持有该公司371股股票,价值2.8万美元。Parkside Financial Bank&Trust在第一季度增加了对DaVita股票的持仓88.6%。Parkside Financial Bank&Trust现在拥有该公司313股股票,价值3.5万美元,上个季度又购买了147股。最后,Wetherby Asset Management Inc.在第一季度将其持有的DaVita股票头寸增加了8.1%。Wetherby Asset Management Inc.在上个季度又购买了154股,现在拥有2,050股该公司股票,价值23.2万美元。对冲基金和其他机构投资者持有该公司86.52%的股票。
DaVita公司简介
(获取评级)
DaVita,Inc.从事医疗保健服务的提供。它通过以下两个部门运作:美国透析和相关实验室服务,以及其他辅助服务和战略倡议。美国透析及相关实验室服务部门在美国为慢性肾功能衰竭患者提供肾脏透析服务。
专题报道
- 免费获取StockNews.com关于DaVita(DVA)的研究报告
- 市场回顾周-3/13-3/17
- 这项具有巨大增长前景的小型技术正在接近买入点
- 不要追逐联邦快递更高,等待回调
- 防御性科技投资组合的3只股票
- 从这3头现金母牛身上榨取分红
接受《达维塔日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对DaVita和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧